Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.48 USD | +2.05% | +3.74% | -37.72% |
04-30 | Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating | MT |
04-26 | Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.72% | 586M | |
+19.28% | 84.56B | |
-26.95% | 72.41B | |
+1.97% | 27.73B | |
-7.35% | 17.75B | |
-0.39% | 17.11B | |
+4.69% | 16.03B | |
+8.14% | 13.72B | |
+69.96% | 13.07B | |
+6.88% | 12.91B |
- Stock Market
- Equities
- ACCD Stock
- News Accolade, Inc.
- Guggenheim Upgrades Accolade to Buy From Neutral, Price Target is $16